tiprankstipranks
Emergent Biosolutions (EBS)
NYSE:EBS
US Market

Emergent Biosolutions (EBS) Income Statement

Compare
1,273 Followers

Emergent Biosolutions Income Statement

Last quarter (Q4 2024), Emergent Biosolutions's total revenue was $189.30M, a decrease of -31.56% from the same quarter last year. In Q4, Emergent Biosolutions's net income was $-31.30M. See Emergent Biosolutions’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.01B$ 1.05B$ 1.12B$ 1.79B$ 1.56B
Gross Profit
$ 1.01B$ 343.90M$ 427.20M$ 1.04B$ 1.03B
Operating Expenses
$ 1.15B$ 1.04B$ 593.20M$ 640.90M$ 597.60M
Depreciation and Amortization
$ 108.80M$ 125.10M$ 148.90M$ 126.30M$ 114.40M
EBITDA
$ 36.90M$ -505.30M$ -32.90M$ 458.20M$ 549.00M
Operating Income
$ -108.70M$ -726.40M$ -166.00M$ 352.60M$ 433.80M
Other Income/Expenses
$ -34.20M$ -4.80M$ -53.00M$ -38.20M$ -26.60M
Pretax Income
$ -142.90M$ -731.20M$ -221.70M$ 314.40M$ 407.20M
Net Income
$ -190.60M$ -760.50M$ -223.80M$ 219.50M$ 305.80M
Per Share Metrics
Basic EPS
$ -3.60$ -14.85$ -4.47$ 4.10$ 5.79
Diluted EPS
$ -3.60$ -14.85$ -4.47$ 4.06$ 5.67
Weighted Average Shares Outstanding
53.00M 51.20M 50.10M 53.50M 52.70M
Weighted Average Shares Outstanding (Diluted)
53.00M 51.20M 50.10M 54.10M 53.80M
Currency in USD

Emergent Biosolutions Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis